Arena Pharmaceuticals, Inc. Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
Published: Mar 04, 2013
"2012 was a momentous year for Arena with the FDA approval of our first drug, BELVIQ," said Jack Lief, Arena's President and Chief Executive Officer. "It is a time of great pride, with BELVIQ representing the first of what we expect will be many novel treatments resulting from our validated research and development approach."